Aytu BioPharma Inc. (AYTU)
1.18
-0.03 (-2.48%)
At close: Mar 31, 2025, 2:06 PM
Aytu BioPharma Balance Sheet Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 |
| Cash & Equivalents | 20.01M | 22.98M | 19.36M | 49.65M | 48.08M | 11.04M | 7.01M | 802.33K | 8.05M | 7.35M | 2.64M | 1.86K | 109.00 | 3.99K | 1.54K | 13.61K | 37.64K | 23.36K |
| Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.04M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | -1.38M | n/a | -10.91M | -1.8M | n/a | n/a | n/a | n/a | -41.43K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 2.23M | 792K | 766K | 465K | 32.98K | 2.2K | 4.72K | 2.89K | 216.36K | 339.82K | 457.25K | -770.06K | n/a | n/a | n/a | n/a | n/a | n/a |
| Receivables | 23.62M | 28.94M | 21.71M | 28.18M | 5.63M | 1.74M | 578.78K | 528.04K | 162.43K | 157.06K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Inventory | 12.63M | 11.99M | 10.85M | 16.34M | 10M | 1.44M | 1.34M | 1.31M | 524.71K | 39.44K | 10.45K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 5.63M | 8.91M | 8.01M | 11.07M | 11.71M | 1.21M | 540.01K | 385.97K | 337.54K | 534.3K | 171.00 | n/a | 77.00 | 234.00 | 172.00 | 257.00 | 164.00 | n/a |
| Total Current Assets | 61.89M | 72.83M | 59.93M | 105.23M | 74.97M | 15.43M | 9.47M | 3.03M | 10.12M | 8.08M | 3.3M | 1.86K | 186.00 | 4.23K | 1.72K | 13.87K | 37.81K | 23.36K |
| Property-Plant & Equipment | 1.52M | 3.87M | 6.3M | 8.7M | 892.61K | 203.73K | 219K | 647.25K | 231.43K | 30K | 57K | 7.52K | 12.46K | 18.61K | 25.37K | 27.98K | 36.27K | 36.31K |
| Goodwill & Intangibles | 52.45M | 58.97M | 70.63M | 151.27M | 76.94M | 19.08M | 11.37M | 11.32M | 13.77M | 9.77M | 8.2M | 770.35K | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 56.2M | 63.63M | 77.69M | 160.43M | 77.87M | 19.29M | 11.59M | 11.97M | 14.22M | 10.14M | 8.71M | 7.81K | 12.46K | 18.61K | 25.37K | 27.98K | 36.27K | 36.31K |
| Total Assets | 118.09M | 136.46M | 137.62M | 265.67M | 152.84M | 34.72M | 21.06M | 15M | 24.34M | 18.23M | 12.02M | 9.67K | 12.65K | 22.84K | 27.09K | 41.85K | 74.07K | 59.67K |
| Account Payables | 10.44M | 13.48M | 10.99M | 19.25M | 11.64M | 2.13M | 2.12M | 2.22M | 2.32M | 1.2M | 310.00 | 6.84K | 5.84K | 330.00 | 477.00 | n/a | n/a | 1.74K |
| Deferred Revenue | n/a | 46.8M | n/a | 57.23M | 339.34K | n/a | n/a | n/a | n/a | 85.71K | 85.71K | 264.17K | n/a | n/a | n/a | n/a | n/a | n/a |
| Short-Term Debt | 4.25M | 85K | 3.91M | 24.7M | 1.28M | n/a | n/a | n/a | n/a | n/a | 30.98K | 99.51K | 68.05K | 52.3K | 77.6K | 54.62K | 48.12K | 34.4K |
| Other Current Liabilities | 47.54M | 55.45M | 49.55M | 65.48M | 15.67M | 3.24M | 1.28M | 1.39M | 7.78M | 197.95K | 19.21K | 14.17K | 8.47K | 5.8K | 4.62K | 820.00 | n/a | 4.73K |
| Total Current Liabilities | 62.23M | 69.02M | 64.44M | 109.44M | 28.31M | 5.37M | 3.39M | 3.61M | 10.1M | 1.48M | 6.09M | 120.53K | 82.36K | 58.43K | 82.7K | 55.44K | 48.12K | 40.87K |
| Long-Term Debt | 10.88M | 14.71M | 14.28M | 5.43M | 725K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Liabilities | 17.27M | 13.38M | 12.81M | 13.23M | 28.79M | 22.26M | 4.24M | 7.39M | 4.15M | 664K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Liabilities | 28.15M | 28.09M | 27.09M | 18.66M | 29.51M | 22.26M | 4.24M | 7.39M | 4.15M | 1.13M | 554.41K | n/a | 73.9K | 52.63K | 78.08K | 54.62K | 48.12K | 36.14K |
| Total Liabilities | 90.38M | 97.11M | 91.53M | 128.1M | 57.82M | 27.63M | 7.64M | 11M | 14.26M | 2.61M | 6.65M | 120.53K | 82.36K | 58.43K | 82.7K | 55.44K | 48.12K | 40.87K |
| Total Debt | 15.13M | 16.36M | 18.19M | 28.35M | 2.01M | n/a | n/a | n/a | n/a | n/a | 4.6M | 99.51K | 68.05K | 52.3K | 77.6K | 54.62K | 48.12K | 34.4K |
| Common Stock | 1K | 1K | 4K | 3K | 12.58K | 1.75K | 179.00 | 82.00 | 374.00 | 1.43K | 790.00 | 414.03K | n/a | n/a | 1K | n/a | 205.25K | n/a |
| Retained Earnings | -319.97M | -304.13M | -288.47M | -178.3M | -120.01M | -106.39M | -79.26M | -69.07M | -46.56M | -18.38M | -10.66M | -568.7K | -500 | -500 | -500 | -254.14K | -195.75K | -138.57K |
| Comprehensive Income | n/a | n/a | -0.00 | 0.00 | n/a | n/a | 0.00 | -246K | -112K | -5M | -33K | 10.47M | -510.89K | -451.21K | -314.41K | -1.26K | 449.00 | 417.00 |
| Shareholders Equity | 27.72M | 39.36M | 46.09M | 137.57M | 95.02M | 7.09M | 13.42M | 4M | 10.09M | 15.62M | 5.37M | -110.86K | -69.72K | -35.59K | -55.61K | -13.58K | 25.96K | 18.81K |
| Total Investments | -762K | -1.38M | n/a | -10.91M | -1.8M | n/a | n/a | n/a | 1.04M | -41.43K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |